pharma news

News

An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.

News

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy, a major cause of blindness.

News

AstraZeneca's light chain (AL) amyloidosis candidate anselamimab has failed a phase 3 readout, but showed efficacy in a patient subgroup.

News

LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.

News

Federal staffers voice their anger and disgust as thousands of the Trump administration's reduction-in-force job losses are finalised.

News

An obesity therapy developed by Hengrui Pharma and Kailera is being prepared for its first regulatory submission, in China.